ÇEFLE, A. Et Al. 2016. Effects of Infliximab Treatment in Terms of Metabolic Parameters and Insulin Resistence in Ankylosing Spondylitis Patients. EULAR 2016 , (Londrina, Brazil), 11332-1133.

ÇEFLE, A., TEMİZ KARADAĞ, D., BİLEN, M., SENER, S., ÖZDEMİR IŞIK, Ö., & YAZICI, A., (2016). Effects of Infliximab Treatment in Terms of Metabolic Parameters and Insulin Resistence in Ankylosing Spondylitis Patients . EULAR 2016 (pp.11332-1133). Londrina, Brazil

ÇEFLE, AYŞE Et Al. "Effects of Infliximab Treatment in Terms of Metabolic Parameters and Insulin Resistence in Ankylosing Spondylitis Patients," EULAR 2016, Londrina, Brazil, 2016

ÇEFLE, AYŞE Et Al. "Effects of Infliximab Treatment in Terms of Metabolic Parameters and Insulin Resistence in Ankylosing Spondylitis Patients." EULAR 2016 , Londrina, Brazil, pp.11332-1133, 2016

ÇEFLE, A. Et Al. (2016) . "Effects of Infliximab Treatment in Terms of Metabolic Parameters and Insulin Resistence in Ankylosing Spondylitis Patients." EULAR 2016 , Londrina, Brazil, pp.11332-1133.

@conferencepaper{conferencepaper, author={AYŞE ÇEFLE Et Al. }, title={Effects of Infliximab Treatment in Terms of Metabolic Parameters and Insulin Resistence in Ankylosing Spondylitis Patients}, congress name={EULAR 2016}, city={Londrina}, country={Brazil}, year={2016}, pages={11332-1133} }